ReviewCells2024

Induced Pluripotent Stem Cells and CRISPR-Cas9 Innovations for Treating Alpha-1 Antitrypsin Deficiency and Glycogen Storage Diseases.

Colin Walsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.